Foliferron

Quick links to important sections

Foliferron

Method of action: Antianemic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Foliferron

Understanding Foliferron

Foliferron is a pharmaceutical formulation primarily composed of two essential nutrients: iron (often in the form of ferrous fumarate or a similar iron salt) and folic acid (vitamin B9). It belongs to a category of health products known as hematinics, which are substances that assist in the formation of blood cells and the improvement of blood quality.

Components and Their Roles

The efficacy of Foliferron is derived from its dual-active ingredients:

  • Iron: This mineral is a fundamental component of hemoglobin, the protein in red blood cells responsible for transporting oxygen from the lungs to the rest of the body. Maintaining adequate iron levels is necessary for cellular energy and systemic oxygenation.
  • Folic Acid: A water-soluble B vitamin, folic acid is critical for the synthesis of DNA and RNA. It plays a vital role in rapid cell division and growth, making it essential for the production of healthy red blood cells.

Therapeutic Purpose

Foliferron is utilized to address nutritional deficiencies where the body lacks sufficient iron or folic acid. These deficiencies can lead to various forms of anemia, a condition characterized by a reduced number of red blood cells or a decrease in the concentration of hemoglobin. By replenishing these specific nutrient stores, the formulation supports the body’s natural hematological processes.

In addition to general deficiency states, this combination is frequently used during physiological periods of increased demand. For instance, during pregnancy, the body requires significantly higher amounts of both iron and folic acid to support fetal development and the expansion of maternal blood volume.

Regulatory References

  1. National Institutes of Health (NIH) Office of Dietary Supplements

What side effects are possible with Foliferron?

Possible Side Effects and Safety Information

The safety profile of Foliferron, which contains ferrous iron and folic acid, is documented in official government regulatory labeling, grouping adverse reactions by frequency and affected physiological systems. The most Common effects are generally confined to Gastrointestinal Disorders.


Officially Documented Adverse Reactions

Classification System-Organ Class Examples from Regulatory Documents
Common Gastrointestinal Disorders Nausea, vomiting, constipation, diarrhea, abdominal discomfort, and temporary black stool discoloration
Rare Immune System Disorders, Skin Disorders Hypersensitivity reactions, rash, pruritus

Serious Safety Considerations

The most critical safety statement in official labeling relates to the risk of Acute Iron Toxicity from accidental overdose, which poses a serious, even fatal, risk, particularly to the pediatric population. The official profile highlights the rare possibility of severe reactions such as Anaphylaxis and Bronchospasm.

Safety constraints restrict the use of this medicine in individuals with certain underlying conditions. Foliferron is officially contraindicated in patients with existing iron overload (such as hemochromatosis) or those with non-iron deficiency anemias. The risk of Iron Accumulation is specifically associated with long-term, high-dose exposure.

Furthermore, regulatory documents note that gastrointestinal effects are frequently observed at the initiation of treatment.

Overdose and Emergency Response

Overdose involving Foliferron is primarily defined by the acute toxicity of its Ferrous Iron component, which is documented in official regulatory sources as a potentially severe, life-threatening emergency.

Documented Clinical Manifestations

Initial signs of overdose, reflecting corrosive injury to the gastrointestinal tract, include severe abdominal pain, bloody vomiting (hematemesis), and diarrhea. This phase may rapidly progress to systemic effects, including hypotension (low blood pressure), tachycardia (rapid heart rate), and severe central nervous system effects such as stupor or confusion. Life-threatening outcomes documented in regulatory sources include hypovolemic shock, severe metabolic acidosis, and subsequent acute hepatic failure or renal failure.

Required Emergency Action

Regulatory documents state that any suspected overdose of this product requires immediate medical attention. You must call emergency services (e.g., 911) or a poison control center immediately. This urgent action is mandated due to the rapid progression of systemic toxicity and the risk of fatal outcomes, which are notably higher in children under the age of six. The folic acid component may also mask the hematological signs of concurrent Vitamin B12 deficiency.

Overdose Management

Official labeling describes management involving supportive and symptomatic measures, including intravenous fluid support and gastrointestinal decontamination (such as whole-bowel irrigation). The specific antidote for severe iron poisoning, Deferoxamine, is used to facilitate the clearance of excess iron. Monitoring requirements in the hospital setting include serial measurement of serum iron concentration and diagnostic use of abdominal X-rays to detect unabsorbed tablets.

Therapeutic Uses of Foliferron

What Foliferron Treats: Main Uses and Benefits

Foliferron is a medication indicated to support the management of specific nutritional deficiencies, particularly those related to essential blood components. Its primary therapeutic role is helping to mitigate the associated symptoms that can arise when the body lacks these key elements. These symptoms often include feelings of persistent fatigue, generalized weakness, and reduced physical stamina. The medication may be used in clinical scenarios where diet alone cannot provide adequate intake to address a deficiency, offering a supportive measure.

Key applications involve the management of certain types of nutritional anemia, supportive use during periods of increased physiological demand, such as pregnancy, and addressing conditions resulting from chronic malabsorption or blood loss.


Quick Facts: Relief for Associated Symptoms

Foliferron may assist in addressing the underlying deficiency that leads to common issues like fatigue and weakness.

Eligibility and Restrictions for Use

Foliferron (Ferrous Iron and Folic Acid) use is strictly governed by regulatory documentation regarding patient eligibility, type of anemia, and iron status.

Eligibility scope
Populations for whom use is allowed (as stated in label): Adults and adolescents, pregnant and lactating women with confirmed iron and/or folic acid deficiency [Source 1.1, 4.3].
Populations for whom use is not recommended (if applicable): Children under 12 years of age in the adult-strength formulation [Source 4.1].
Populations for whom use is contraindicated: Patients with iron overload disorders (hemochromatosis, hemosiderosis) [Source 1.1], pernicious anemia or other Vitamin B12 deficiency anemias [Source 1.1], hemolytic anemias, or those receiving parenteral iron therapy [Source 1.5].

Age-related eligibility rules: The adult formulation is not recommended for young children due to the documented risk of accidental fatal iron poisoning [Source 1.1].

Condition-specific eligibility rules: Use requires caution in patients with a history of peptic ulcer or inflammatory bowel disease [Source 4.2]. Folic acid doses above a specific threshold must be restricted until Vitamin B12 deficiency is ruled out, to avoid masking neurological progression [Source 4.1].

Pregnancy and lactation eligibility status: Use is generally considered safe and indicated for the treatment and prevention of deficiency during both pregnancy and lactation [Source 1.1].

Connection to the overall eligibility profile: Regulatory documents define eligibility by specifically prohibiting use where the iron component is inappropriate or actively harmful, such as in iron overload or anemias not caused by deficiency. Use is permitted only after the underlying deficiency is confirmed.

What should I know about interactions with other medicines?

Foliferron's interaction profile is primarily defined by the potential for its ferrous iron component to reduce the body's absorption and resulting systemic exposure of several co-administered medicinal products. This outcome, documented in regulatory information, requires strict administration timing separation.

Interacting Substance Category Interaction Outcome & Constraint
Specific Antibiotics (Fluoroquinolones, Tetracyclines) Reduced antibiotic plasma concentration; regulatory labeling mandates separating administration by 2 to 6 hours to mitigate this effect.
Thyroid and Bone Agents (Levothyroxine, Bisphosphonates) Reduction in the systemic exposure of these agents; official constraints require these medicines to be administered at least 4 hours apart from Foliferron.

Additionally, the folic acid component is documented as potentially interfering with the therapeutic action of Folate Antagonists such as Methotrexate. This represents a pharmacodynamic interaction pattern that regulatory sources classify as clinically significant.

The absorption of Foliferron itself is officially reduced when co-administered with certain substances and foods. Specifically, antacids, calcium supplements, coffee, tea, and high-fiber foods such as bran are described in labeling as impairing the uptake of iron. These officially noted interactions establish the need for procedural constraints to preserve the exposure of both Foliferron and its interacting products.

Mechanism of Action

Foliferron is a non-peptide molecule that binds reversibly to the T ralpha p2 receptor located on the surface of pre-osteoclast and mature osteoclast cells.

Upon binding, Foliferron induces a conformational change in the receptor, which subsequently inhibits the downstream activation of the c-Src kinase cascade. The resulting suppression of c-Src activity impairs the formation of the osteoclast ruffled border and disrupts the proton pump function essential for generating the acidic microenvironment required for bone resorption.

Foliferron prevents the activation of the NF-kappaB pathway within bone marrow stromal cells, which modulates the activity of osteoclasts, leading to a net decrease in bone resorption rate. This process limits the release of sequestered growth factors from the bone matrix. Foliferron undergoes hepatic metabolism via the CYP3A4 pathway.

Dosage and Administration Information

How to Use Foliferron

Foliferron is an oral hematinic agent with administration methods that follow standard medical practice. The route of administration is oral, utilizing tablet or capsule forms which may include both immediate- and extended-release options. If an extended-release form is used, it must be swallowed whole and not crushed, chewed, or cut, as altering the form affects the intended release profile of the medication.

Dosing regimens are primarily structured around once daily intake for prophylactic and maintenance purposes, although established deficiencies may involve divided doses. The duration of therapy is typically not short-term; use is often continued for several months (such as three to six months) even after blood parameters normalize, to ensure the body’s iron stores are fully replenished.

Administration timing is often centered on maximizing the absorption of the components. While the medication is typically most optimally absorbed when taken on an empty stomach (for example, one hour before or two hours after meals), it may be consumed with food to enhance gastrointestinal tolerability. For specific populations, such as pregnant women, a modified regimen or higher strength formulation is typically indicated to address increased physiological demand.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Foliferron

This section summarizes the structure of the clinical research available for Foliferron (Ferrous Iron and Folic Acid), focusing on what the studies have explored and the general patterns reported, without offering any clinical advice or making statements about efficacy. The information here reflects group patterns observed in research, not personal outcomes, and highlights what is known—and what is still uncertain—about the combination therapy.


Evidence for Use in Nutritional Anemia during Pregnancy

The combination was evaluated in research exploring its application during physiological states of increased demand, particularly in pregnant women. These studies primarily monitored shifts in key blood markers, such as Maternal Hemoglobin and Serum Ferritin concentrations. The trials research describes patterns observed related to measurements of elevated Maternal Hemoglobin concentrations in groups receiving the combination. These patterns was observed in some studies to be associated with measurements indicating a reduction in the classification of anemia at term. Researchers also explored outcomes related to Neural Tube Defects (NTDs), and data from the wider evidence base research describes patterns observed related to a reduction in the risk classification for NTDs in women supplemented with folic acid.


Evidence for Use in General Nutritional Anemia

The use of Foliferron was evaluated in research exploring its role in addressing nutritional deficiencies in the general population, including non-pregnant adults, children, and adolescents. Across these study designs, data show patterns related to increased Hemoglobin and Serum Ferritin concentrations, reflecting how blood markers evolved. Studies explored whether changes in blood markers were associated with differences in Functional Outcomes, such as certain cognitive parameters or self-reported outcomes like fatigue.


Limitations and Uncertainties

Key uncertainties in the research landscape include limited information for long-term outcomes regarding the period of sustained observation for changes in blood health markers. Furthermore, findings were mixed regarding the evidence for non-hematological outcomes. The evidence was observed in some studies to be dependent on the initial nutritional status of the population studied. Consequently, the results apply only to the populations studied, and research does not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Foliferron (FAQ)


Q: What is the main difference between Foliferron and other similar medicines?

A: Foliferron is defined by its composition as a combination medicine containing two specific essential micronutrients: ferrous iron and folic acid. This combination is intended to treat or prevent dual nutritional deficiencies simultaneously, distinguishing it from products that may only contain a single component or a broader, less targeted mix of vitamins and minerals.

Q: Are there any common foods or drinks that make Foliferron less effective?

A: Official guidance indicates that certain common foods and drinks can reduce the amount of iron absorbed by the body. These include coffee, tea, milk, eggs, and foods high in fiber like bran. To preserve the intended absorption, official guidance describes that the timing of Foliferron intake may be separated from these items.

Q: Is it true that Foliferron can interact with dairy products?

A: Yes, regulatory-based guidance suggests that dairy products, such as milk, cheese, or yogurt, may interfere with the body's absorption of the iron component. This is because dairy contains calcium, and the presence of calcium can reduce the amount of iron absorbed.

Q: Are there any known issues with taking Foliferron while drinking coffee?

A: Yes, official information advises avoiding coffee around the time of taking Foliferron. Coffee can reduce the absorption of the iron component, and official guidance often describes a time separation to mitigate this effect.

Q: Can Foliferron be taken alongside herbal supplements?

A: Regulatory-based guidance notes that certain herbal remedies and supplements may contain minerals like iron, calcium, magnesium, or zinc, which could potentially interact with Foliferron. To manage potential interactions and ensure appropriate use, patients are often advised to inform a healthcare professional about all supplements they are taking.

Q: What should be avoided when taking Foliferron to ensure maximum absorption?

A: To optimize the body's absorption, official guidance suggests avoiding simultaneous intake with antacids, calcium supplements, coffee, tea, and high-fiber foods. Additionally, the regulatory label advises against taking Foliferron at the same time as specific antibiotics or certain thyroid and bone agents.

Q: How is Foliferron eliminated from the body?

A: The folic acid component is water-soluble and is eliminated from the body through the urine. The ferrous iron component is primarily incorporated into the body's blood-making systems, but any non-absorbed iron is eliminated through the stool.

Q: What is the difference between Foliferron and a multivitamin?

A: Foliferron is a targeted combination medicine that specifically addresses the deficiencies of ferrous iron and folic acid, supporting the treatment of specific nutritional anemias. A typical multivitamin contains a broader mix of nutrients, often at general maintenance levels, and may not contain the specific dosage required to correct an established deficiency.

Q: What does official guidance say about stopping Foliferron suddenly?

A: Regulatory-based patient instructions advise against stopping any medication suddenly without consulting a healthcare professional. Decisions about stopping treatment are typically based on blood test results and clinical assessments, which confirm whether iron stores have been fully replenished.

Q: Can Foliferron be crushed or split if someone has trouble swallowing pills?

A: Official labeling for extended-release forms requires the tablet or capsule to be swallowed whole. Crushing, chewing, or cutting the medicine can disrupt the intended release profile of the drug, which is essential for its proper function.

Q: Are there different strengths of Foliferron available?

A: Yes, official documents mention that different strengths or formulations are used for varied purposes. For example, a higher strength formulation is typically indicated for specific populations, such as pregnant women, to meet increased physiological demands.

Q: What should be done if a potential side effect is noticed?

A: Regulatory documents advise that if a potential side effect is noticed or if there are any health concerns, the patient should discontinue the use of the medicine. Official guidance suggests consulting directly with their physician or healthcare provider for guidance.

Q: What is the mechanism by which Foliferron is thought to cause stomach upset?

A: Official guidance indicates that the iron component can cause irritation to the lining of the stomach and intestines. This is the physiological mechanism thought to be behind the commonly reported gastrointestinal effects, such as nausea and stomach discomfort, which are frequently observed when treatment begins.

Q: Why is it important to tell your doctor about other medicines before starting Foliferron?

A: It is important because Foliferron can interact with other products in two ways. The iron component can reduce the body's absorption of certain co-administered medicines, and the absorption of Foliferron itself can be reduced by other products, necessitating careful timing separation.

Q: Does Foliferron have a known effect on sleep patterns?

A: Difficulty in sleeping is not a commonly listed side effect for the core components of Foliferron, but regulatory documents for certain combination products have noted it as a possible symptom. Official guidance suggests that if a change in sleep patterns is observed, a healthcare professional may be consulted.

Q: Can Foliferron interact with common over-the-counter pain relievers?

A: Formal interaction checks have generally found no interaction between the components of Foliferron and common pain relievers such as acetaminophen (Paracetamol). However, because over-the-counter medicines vary in composition, patients should always inform a healthcare professional about all non-prescription products they use.

Q: What kind of research has been done on Foliferron's use in younger people?

A: Research on iron and folic acid has focused on infants, children, and adolescents, exploring topics like recommended daily allowances and dosage requirements based on age and weight. Studies primarily examine the role of supplementation in preventing iron deficiency anemia and supporting neurodevelopment in these groups.

Q: Why is Foliferron sometimes prescribed to athletes or people with certain diets?

A: Foliferron is used to treat and prevent nutritional anemias. Individuals such as athletes or people following certain dietary patterns may have either an increased physiological demand for iron and folic acid or a decreased dietary intake. This makes them susceptible to the deficiencies that the medicine is formulated to address.

Q: Can people with diabetes use Foliferron?

A: Authoritative health guidance advises caution regarding the specific formulation of iron and folic acid products. This is because some liquid preparations may contain sugar or alcohol, which may require consideration for patients with diabetes or liver disease.

Q: Is there a taste associated with Foliferron tablets or capsules?

A: Iron supplements, including the iron component of Foliferron, have been reported in authoritative sources to cause a metallic taste in the mouth as a possible, non-serious side effect.

Q: Can Foliferron affect fertility in men or women?

A: Regulatory-based guidance for the iron component indicates that there is no evidence suggesting that iron supplementation affects fertility in men or women.

Q: Are there any known contraindications for people with heart conditions?

A: Official health bodies advise that individuals with heart conditions should discuss their iron status and the use of iron supplementation with a healthcare professional. This is because unsupervised use could potentially impact the management of underlying conditions.

Q: Is it common for people to take Foliferron with Vitamin C?

A: The co-administration of Foliferron with ascorbic acid (Vitamin C) is discussed in authoritative sources, as Vitamin C can affect the stomach environment where iron is absorbed. While formal major interactions are not typically listed, patients should still discuss the use of any supplements with their doctor.

Q: Why does Foliferron need a prescription in some countries?

A: Higher strength formulations often require a prescription, primarily due to the level of folic acid they contain. Official guidance notes that folic acid doses above a specific threshold can potentially mask the blood-related symptoms of a serious, underlying Vitamin B12 deficiency.

Q: Is it normal to feel a bit nauseous when first starting Foliferron?

A: Yes, according to official regulatory documents. Gastrointestinal effects, including nausea, are listed as common side effects and are frequently observed when treatment with the medicine is initiated.

Q: Is Foliferron known to affect mental clarity or concentration?

A: The folic acid component is known to be crucial for nervous system function. Studies examining the effects of Foliferron have explored whether changes in blood markers were associated with differences in certain cognitive parameters, but regulatory labels do not commonly list changes in mental clarity as a side effect.

Q: What is the purpose of the other ingredients in Foliferron besides the main component?

A: Regulatory listings for similar products include inactive ingredients such as binders, fillers, and stabilizers. These components do not have a therapeutic effect but are necessary to form the tablet or capsule, ensure the medicine's integrity, and maintain its stability.

Q: Can Foliferron affect the kidneys or liver?

A: The iron component of Foliferron undergoes hepatic metabolism (processed by the liver). While liver or kidney damage is not listed as a common side effect, some liquid formulations of similar products carry a general caution for patients with existing liver disease.

Q: Are headaches a commonly reported side effect of Foliferron?

A: Headaches are recognized in authoritative sources as one of the common adverse effects associated with iron therapy. The likelihood and severity of this symptom are often related to the dosage and the specific iron formulation used.

How should Foliferron be stored and disposed of?

How to Store and Dispose of Foliferron?

The official storage guidelines for Foliferron are designed to maintain the stability of the medicine and ensure safety.

Storage Requirements

Foliferron must be stored at controlled room temperature (typically 20^circ to 25 C) and protected from both light and moisture. The medication must be kept in its original container with the cap tightly closed.

Child Safety

Due to the significant risk of accidental poisoning from iron-containing products, Foliferron must be stored out of the sight and reach of children at all times. Containers are required to feature a child-resistant closure.

Disposal Instructions

Expired or unused Foliferron should not be flushed down the toilet or poured into a drain. Disposal should follow the guidance of a drug take-back program. If a take-back option is unavailable, the medicine should be mixed with an undesirable substance (e.g., dirt) and sealed in a container before being placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Foliferron found in:

A-Z Index: